L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 5.06 NOK 0.8%
Market Cap: 345.4m NOK

Income Statement

Earnings Waterfall
Lytix Biopharma AS

Revenue
10.8m NOK
Operating Expenses
-93.5m NOK
Operating Income
-82.8m NOK
Other Expenses
1.9m NOK
Net Income
-80.9m NOK

Income Statement
Lytix Biopharma AS

Rotate your device to view
Income Statement
Currency: NOK
Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
1
N/A
11
+683%
1
-87%
1
+5%
4
+169%
4
N/A
15
+264%
14
-1%
11
-26%
Operating Income
Operating Expenses
(48)
(62)
(59)
(60)
(77)
(77)
(102)
(105)
(101)
(106)
(93)
(94)
Selling, General & Administrative
(32)
(21)
(24)
(24)
(20)
(23)
(24)
(26)
(24)
(25)
(22)
(20)
Research & Development
(29)
(35)
(42)
(42)
(46)
(56)
(68)
(68)
(63)
(68)
(56)
(60)
Depreciation & Amortization
0
0
(0)
(0)
(1)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
Other Operating Expenses
12
(6)
7
6
(10)
2
(10)
(12)
(12)
(12)
(13)
(12)
Operating Income
(48)
N/A
(62)
-30%
(59)
+5%
(58)
+1%
(66)
-13%
(75)
-15%
(100)
-33%
(101)
-1%
(97)
+4%
(91)
+6%
(78)
+14%
(83)
-6%
Pre-Tax Income
Interest Income Expense
0
0
0
0
10
0
0
0
9
1
1
1
Total Other Income
(0)
(1)
8
15
(0)
15
9
3
(0)
4
1
0
Pre-Tax Income
(48)
N/A
(63)
-31%
(51)
+19%
(43)
+15%
(56)
-30%
(60)
-8%
(91)
-51%
(99)
-8%
(88)
+11%
(86)
+2%
(76)
+12%
(81)
-6%
Net Income
Income from Continuing Operations
(48)
(63)
(51)
(43)
(56)
(60)
(91)
(99)
(88)
(86)
(76)
(81)
Net Income (Common)
(48)
N/A
(63)
-31%
(51)
+19%
(43)
+15%
(56)
-30%
(60)
-8%
(91)
-51%
(99)
-8%
(88)
+11%
(86)
+2%
(76)
+12%
(81)
-6%
EPS (Diluted)
-1.24
N/A
-1.62
-31%
-1.27
+22%
-1.11
+13%
-1.39
-25%
-1.5
-8%
-2.28
-52%
-2.45
-7%
-2.16
+12%
-2.09
+3%
-1.71
+18%
-1.63
+5%